VeriMomsalicyloyl oligopeptide-143은 임신 중 안전한가요?
No harmonised CLP classification, no CIR or SCCS safety assessment specifically for salicyloyl oligopeptide-143, and no peer‑reviewed reproductive/toxicity studies identified (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, ECHA dossiers, CosIng, PubChem, EWG). The only plausible theoretical concern is that the salicyloyl group could release salicylic acid, but there is no direct evidence that this ingredient causes reproductive toxicity. Therefore hazard = 0 (no evidence), mechanism = 1 (theoretical only: potential release of salicylate), exposure = 1 (topical cosmetic use — low but potentially measurable absorption).
Related ingredients
Frequently asked questions
- salicyloyl oligopeptide-143은 임신 중 안전한가요?
- No harmonised CLP classification, no CIR or SCCS safety assessment specifically for salicyloyl oligopeptide-143, and no peer‑reviewed reproductive/toxicity studies identified (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, ECHA dossiers, CosIng, PubChem, EWG). The only plausible theoretical concern is that the salicyloyl group could release salicylic acid, but there is no direct evidence that this ingredient causes reproductive toxicity. Therefore hazard = 0 (no evidence), mechanism = 1 (theoretical only: potential release of salicylate), exposure = 1 (topical cosmetic use — low but potentially measurable absorption).
- salicyloyl oligopeptide-143은 모유 수유 중 안전한가요?
- Same rationale as pregnancy. No specific data showing transfer into milk or effects on lactation; theoretical concern only via possible salicylate release. For normal cosmetic topical use exposure is expected to be low.
- salicyloyl oligopeptide-143은 아기 피부에 안전한가요?
- No infant-specific toxicology or clinical data located. Hazard remains 0 (no evidence). Mechanistic concern is theoretical only (possible salicyloyl → salicylic acid). Exposure score increased by +1 for infants due to immature barrier and higher surface‑area‑to‑weight, so e = 2 (moderate relative exposure).
- VeriMom은 salicyloyl oligopeptide-143을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 salicyloyl oligopeptide-143을 87/100 (낮은 위험)로 평가합니다.
- 임신 중 salicyloyl oligopeptide-143 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.